This cohort study evaluates the association of coffee consumption with disease progression and death in patients with advanced or metastatic colorectal cancer.
This prognostic study uses data from patients with outpatient medical or gynecologic oncology encounters to investigate the validity of a machine learning algorithm to predict patient 180-day mortality.
This cohort study uses data from an existing cohort of patients undergoing resection of pancreatic cancer to assess the overall survival of patients treated with neoadjuvant FOLFIRINOX after surgery for pancreatic ductal adenocarcinoma.
This cohort study uses data from the National Cancer Database to assess the association between adjuvant chemotherapy and survival in patients with node-negative early-stage non–small cell lung cancer (NSCLC) with vs without high-risk pathologic features.
This randomized clinical trial evaluates the efficacy and safety of nab-paclitaxel vs paclitaxel in patients with platinum-refractory metastatic urothelial cancer.
This systematic review and meta-analysis assesses the association of the addition of daratumumab to backbone multiple myeloma regimens with progression-free survival among patients with cytogenetically defined high-risk multiple myeloma.
This open-label phase 1 study assesses the antitumor activity, tolerability, and safety of dostarlimab for patients with recurrent or advanced deficient mismatch repair endometrial cancer that has progressed after platinum-containing chemotherapy.
This randomized phase 2 clinical trial assesses the efficacy and safety of plinabulin compared with pegfilgrastim for the prevention of chemotherapy-induced neutropenia following docetaxel chemotherapy in adult patients with non–small lung cancer.
This randomized clinical trial assesses the efficacy of nivolumab plus ipilimumab in the treatment of patients with advanced hepatocellular carcinoma who have been previously treated with sorafenib.
This cross-sectional survey study examines whether Black and White men with prostate cancer differ in their willingness to discuss clinical trials with their physicians, and if so, whether patient-level barriers are associated with racial differences.
This nonrandomized clinical trial evaluates the use of doxorubicin and pembrolizumab in patients with metastatic/unresectable anthracycline-naive sarcoma.
This prospective observational study assesses changes in treatment plans for patients with lung cancer and qualifies the types of changes observed as a direct result of the coronavirus disease 2019 pandemic.
This case series examines HPV seropositivity and antibody levels in a cohort of older men who have sex with men.
This narrative review discusses the use of postoperative radiotherapy in men with prostate cancer.
A 72-year-old man with metastatic appendiceal adenocarcinoma undergoing chemotherapy with capecitabine plus oxaliplatin presents with lower abdominal pain and watery, large-volume diarrhea up to 15 times per day for the previous 3 weeks. What is your diagnosis?
This Viewpoint how the coronavirus disease 2019 pandemic can reshape care in patients with cancer to focus on discouraging unnecessary in-person visits, testing, and low-value treatments.
This Viewpoint suggests a new dosage for pembrolizumab treatment that could decrease patients’ exposure risk to COVID-19.
This Viewpoint highlights the problem of social isolation and distress experienced by patients with cancer during the era of COVID-19, as well as strategies for clinicians to support patients through the pandemic.
This Viewpoint discusses the loosening of Medicare & Medicaid restrictions regarding telemedicine during the coronavirus disease 2019 (COVID-19) pandemic.
In this essay, an experienced oncologist mourns the loss of personal connection with patients and their families that has resulted from the social distancing of the COVID-19 era.
Create a personal account or sign in to: